“…7). CRISPR-mediated screens combine high-throughput, single-cell sequencing technologies with genome-wide sgRNA targeting libraries optimized for gene KO (Sanjana et al, 2014;Doench et al, 2016;Morgens et al, 2017;Wang et al, 2018;Liu et al, 2019), activation (Horlbeck et al, 2016;Joung et al, 2017;Chong et al, 2018;Liu et al, 2018b;Sanson et al, 2018), and silencing (Horlbeck et al, 2016;Liu et al, 2017;Sanson et al, 2018) applications. Recent applications of CRISPR-screening have produced new experimental pipelines that permit the unambiguous contribution of risk-associated genes to disease phenotypes (Thyme et al, 2019) and the determination of cellular-lineage and heredity in developmental studies (McKenna et al, 2016;Raj et al, 2018).…”